What check size does Keith Lenden write?

Keith Lenden typically writes checks of $50K – $150M.

Where did Keith Lenden go to school?

Keith Lenden studied at Kauffman Fellow (Jeff Timmons Leadership Award Recipient); University of California, Berkeley, Haas School of Business (MBA); Thayer School of Engineering, Dartmouth College (BE, Engineering).

Keith Lenden

Venture Partner at ARCH Venture Partners

San Carlos, California

Writes $50K – $150M checks · typically $25M

Kauffman Fellow · Class 16

Find your path to Keith

251 people in our graph share verified history with Keith — schools, employers, funds. One of them is your warm intro.

Ren RileyunlockedKeith: together at Dartmouth College (1992–1995)

×4Keith: together at Dartmouth College

×7Keith: together at ARCH Venture Partners

About

Keith Lenden is a Kauffman Fellow, a member of Class 16 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at ARCH Venture Partners in United States.

Experience

Essential NeuroVentures, LLCFounder & Managing Director2026
ARCH Venture PartnersVenture Partner2017 — 2025San Francisco Bay Area
Autobahn Therapeutics, Inc.Co-Founder & CEO2018 — 2019
Boundless BioCo-Founder & CEO2018 — 2019San Diego, California, United States
Esperion TherapeuticsVice President, Corporate Development & Strategy2013 — 2015Ann Arbor, MI
Abide TherapeuticsCo-Founder & CEO2011 — 2013Greater San Diego Area
MaxygenVice President, Product & Business Development2007 — 2013San Francisco Bay Area
ReceptosCo-Founder & CEO2008 — 2009Greater San Diego Area
LEK ConsultingConsultant1995 — 1999Greater Boston Area

Skills & more

Product Management2Entrepreneurship6Cross-functional Team Leadership9Business Development11Financial Modeling3Business Strategy8Biopharmaceuticals10Strategy36Leadership5Patents2Technology Evaluation1Clinical Development6

+8 more

Drug DevelopmentEarly-stage StartupsMergersDrug DiscoveryManagement ConsultingR&DMedical DevicesBiotechnology

From Keith's professional profile.

Frequently asked questions

Who is Keith Lenden?: Keith Lenden is a Kauffman Fellow, a member of Class 16 of the two-year venture capital leadership program run by Kauffman Fellows. The program's member directory lists them at ARCH Venture Partners in United States.
What check size does Keith Lenden write?: Keith Lenden typically writes checks of $50K – $150M.
Where did Keith Lenden go to school?: Keith Lenden studied at Kauffman Fellow (Jeff Timmons Leadership Award Recipient); University of California, Berkeley, Haas School of Business (MBA); Thayer School of Engineering, Dartmouth College (BE, Engineering).

Same school

Also attended University of California, Berkeley, Haas School of Business978

Mark FiorentinoInvestor at Index Ventures Rishi ModiInvestor at GV (Google Ventures)Yibo NianInvestment Director at Intel Capital Zhenyu TangInvestment Director at Intel Capital DennisDirector of Trading at Pantera Capital Anna ChenInvestor at Madrona Venture Group

+ 972 more

Also attended Dartmouth College662

Scott SandellExecutive Chairman & Chief Investment Officer at NEA James DetweilerVP of Investments at Felicis Ventures Ben RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment Partners Jeffrey PaineFounding Partner at Golden Gate Ventures

+ 656 more

Shared employers

Also worked at ARCH Venture Partners37

Patrick EnnisVenture Partner at Madrona Venture Group Steve GillisManaging Director at ARCH Venture Partners Clinton BybeeCo-founder & Managing Director, Emeritus at ARCH Venture Partners Jason DorenGeneral Counsel at ARCH Venture Partners Carol SuhPartner at ARCH Venture Partners Sean KendallPartner (Europe) at ARCH Venture Partners

+ 31 more

Also worked at Boundless Bio9

Jakob LovenPartner at Nextech Invest Fabio PucciPartner at Arkin Capital Lucio IannoneManaging Director at JDRF T1D Fund Jonathan LimVenture Partner at ARCH Venture Partners Zachary D. HornbyExecutive Officer, Director at Boundless Bio James LeeVP, Business Development at Valora Therapeutics

+ 3 more

Also worked at Esperion Therapeutics9

Nicole VitulloInvestor at Arboretum Ventures Jan GarfinkleFounder and Managing Partner at Arboretum Ventures Scott BraunsteinVice-Chairman of the Board and Director at atai Life Sciences Jeff BerkowitzEquity Partner at Recode Ventures Alan FuhrmanExecutive Officer at TYRA Biosciences Craig ThompsonChief Executive Officer at Cerevance

+ 3 more

Also worked at Maxygen10

Jamie BacherEntrepreneur-In-Residence at The Innovation Space Ruchita SinhaGeneral Partner at AV8 Ventures Josh SilvermanInvestor at Baruch Future Ventures Gjalt HuismanInvestor at Baruch Future Ventures Jan Møller MikkelsenPresident at Ascendis Pharma A/S Frances H. ArnoldVenture Partner at Catalio Capital Management, LP

+ 4 more